Nothing said here yet.
to join the conversation.
| Finn Patrick JohnPresident and COO | Sell | 2,245 | $302.2K | Fri, Oct 23 |
| Laponis AdamChief Financial Officer | Sell | 2,462 | $384.8K | Fri, Oct 9 |
| Leproust Emily M.Chief Executive Officer | Sell | 1,840 | $368.8K | Mon, Oct 5 |
| Leproust Emily M.Chief Executive Officer | Sell | 1,017 | $205.8K | Mon, Oct 5 |
| Leproust Emily M.Chief Executive Officer | Sell | 481 | $96.8K | Mon, Oct 5 |
| Leproust Emily M.Chief Executive Officer | Sell | 432 | $88.0K | Mon, Oct 5 |
| Leproust Emily M.Chief Executive Officer | Sell | 297 | $61.1K | Mon, Oct 5 |
| Leproust Emily M.Chief Executive Officer | Sell | 290 | $59.4K | Mon, Oct 5 |
| Leproust Emily M.Chief Executive Officer | Sell | 146 | $30.2K | Mon, Oct 5 |
| Leproust Emily M.Chief Executive Officer | Sell | 45 | $9.3K | Mon, Oct 5 |
| Leproust Emily M.Chief Executive Officer | Sell | 45,736 | $8.6M | Fri, Oct 2 |
| Finn Patrick JohnPresident and COO | Sell | 25,714 | $4.9M | Fri, Oct 2 |
Key players include Beam Therapeutics, Twist Bioscience, Sangamo, Editas Medicine and Tessera Therapeutics. Profiles cover gene-writing technologies, products, applications, trends and competition.Dublin, Oct.
Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "Long Oligo Pool Synthesis for Capture Global Market Report 2026" has been added to ResearchAndMarkets.com's offering.
Conestoga Capital Advisors, an asset management company, released its third-quarter 2026 investor letter. The letter can be downloaded here.
Twist Bioscience launched Twist Express Screening Antibodies, a high throughput, cell free service that converts customer defined sequences into purified IgG and related formats with SPR binding characterization, with quantities from 5 µg to 20 µg and…
Key TakeawaysTwist Bioscience and 10x Genomics both rose 12% today, and neither company had news of its own. ICON rose 13% after its third-quarter gross bookings jumped 26.
Fred Alger Management, an investment management company, released its third-quarter 2026 investor letter for “Alger Small Cap Growth Fund”. The letter can be downloaded here.
Polen Capital, an investment management company, released its “Polen 5Perspectives Small-Mid Growth Strategy” Q3 2026 investor letter. A copy of the letter can be downloaded here.
Key TakeawaysTwist Bioscience shares fell 9% today with no company news, as Illumina dropped 5% in a broad selloff in tech and AI stocks.
Recent industry analysis identified Twist Bioscience as a key company in the expanding global biofoundry-as-a-service market, which is projected to reach about US$4.38 billion by 2030, reflecting growing adoption of AI-enabled, automated biological…